Facebook Twitter Instagram
    RECENT:
    • EDD 2022 – Spain
    • EDD 2022 – Russia
    • EDD 2022 – Portugal
    • EDD 2022 – Germany
    • EDD 2022 – France
    • EDD 2022 – Croatia
    • EDD 2022 – Belgium
    • EDD 2022 – Flyer
    • EDD 2021 – Italia
    • EDD 2021 – Belgium
    Facebook Twitter Instagram
    Tuesday, February 7
    European Depression Association
    Facebook Twitter Instagram
    • Home
    • About us
    • Board
    • Manifesto
    • EDD 2022
    • Previous editions
    • Articles
    • Links
    • Contact US
    European Depression Association
    Home»Articles»Pharmacological prevention of suicide in patients with major mood disorders

    Pharmacological prevention of suicide in patients with major mood disorders

    0
    By Webmaster on 13 May 2019 Articles
    Share
    Facebook Twitter LinkedIn WhatsApp
    Neuroscience & Biobehavioral Reviews - Vol. 37, Issue 10, Part 1, December 2013, Pages 2398-2403 https://doi.org/10.1016/j.neubiorev.2012.09.009
    ZoltanRihmer,
    XeniaGonda
    Highlights
    • Suicide risk in mood disorders is related to presence and severity of depressive episode.
    • Appropriate pharmacotherapy markedly reduces suicide morbidity and mortality.
    • Slightly elevated suicide risk in patients on antidepressants may be due to unrecognized bipolarity.

    Click to lin to the article

    The risk of self-destructive behavior in mood disorders is an inherent phenomenon and suicidal behavior in patients with unipolar or bipolar major mood disorders strongly relates to the presence and severity of depressive episodes. Consequently, early recognition, and successful acute and long-term treatment of depressive disorders is essential for suicide prevention in such patients. Large-scale, retrospective and prospective naturalistic long-term clinical studies, including severely ill, frequently suicidal depressives show that appropriate pharmacotherapy markedly reduces suicide morbidity and mortality even in this high-risk population. Supplementary psycho-social interventions further improve the effect. The slightly elevated (but in absolute sense quite low) risk of suicidal behavior among patients taking antidepressants compared to those taking placebo in randomized controlled antidepressant trials on unipolar major depression might be the consequence of the depression-worsening potential of antidepressant monotherapy in subthreshold and mixed bipolar depressed patients included in these trials and falsely diagnosed as suffering from unipolar major depression. Concurrent depression-focused psychotherapies increase the effectiveness of pharmacotherapy and this way contribute to suicide prevention for patients with mood disorders.

    Share. Facebook Twitter LinkedIn WhatsApp

    Related Articles

    “G.T. Mixed States Rating Scales”, or “G.T. MSRS”

    22 May 2019

    Early Intervention in Bipolar Disorder

    13 May 2019

    Depression and suicide on Gotland: an intensive study of all suicides before and after a depression-training programme for general practitioners

    13 May 2019

    Comments are closed.

    THE HANDBOOK ON DEPRESSION AND MOOD DISORDER

    Croatian versionFrench versionItalian versionLatvian versionPortuguese versionRussian versionSpanish versionTurkey version

    Facebook Twitter Instagram LinkedIn
    • Home
    • About us
    • Contact us
    • Cookie Policy (EU)
    © 2023 European Depression Association. Designed by AR Engineering.

    Type above and press Enter to search. Press Esc to cancel.

    Manage Cookie Consent
    To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
    Functional Always active
    The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
    Preferences
    The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
    Statistics
    The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
    Marketing
    The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
    Manage options Manage services Manage vendors Read more about these purposes
    View preferences
    {title} {title} {title}